After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Rein Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Rein Therapeutics Inc is $37.44M. A total of 0.84 million shares were traded on the day, compared to an average of 873.50K shares.
In the most recent transaction, Voss Capital, LP bought 178,392 shares of RNTX for 1.39 per share on Oct 28 ’25. After the transaction, the 10% Owner now owns 500,000 company shares. In a previous transaction on Oct 27 ’25, Voss Capital, LP bought 97,482 shares at 1.37 per share. RNTX shares that 10% Owner owns now total 822,258.
Among the insiders who bought shares, Voss Capital, LP acquired of 30,176 shares on Oct 24 ’25 at a per-share price of $1.39. This resulted in the 10% Owner holding 729,616 shares of RNTX after the transaction. In another insider transaction, WINDSOR JAMES BRIAN bought 400 shares at $2.24 per share on Dec 05 ’24. Company shares held by the President and CEO now total 239.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RNTX has a high of $4.07 and a low of $1.04.
As of this writing, RNTX has an earnings estimate of -$0.22 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$0.22. The company reported an EPS of -$0.27 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RNTX’s latest balance sheet shows that the firm has $45.93M in Cash & Short Term Investments as of fiscal 2021. There were $162.00k in debt and $4.51M in liabilities at the time. Its Book Value Per Share was $0.13, while its Total Shareholder’s Equity was $43.90M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RNTX is Buy with a score of 4.33.
